1104 related articles for article (PubMed ID: 15948994)
21. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
Thaçi D; Reitamo S; Gonzalez Ensenat MA; Moss C; Boccaletti V; Cainelli T; van der Valk P; Buckova H; Sebastian M; Schuttelaar ML; Ruzicka T;
Br J Dermatol; 2008 Dec; 159(6):1348-56. PubMed ID: 18782319
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
Fleischer AB; Abramovits W; Breneman D; Jaracz E;
J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies.
Paller AS; Lebwohl M; Fleischer AB; Antaya R; Langley RG; Kirsner RS; Blum RR; Rico MJ; Jaracz E; Crowe A; Linowski GJ;
J Am Acad Dermatol; 2005 May; 52(5):810-22. PubMed ID: 15858471
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
Hanifin JM; Paller AS; Eichenfield L; Clark RA; Korman N; Weinstein G; Caro I; Jaracz E; Rico MJ;
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
[TBL] [Abstract][Full Text] [Related]
29. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
Abramovits W; Fleischer AB; Jaracz E; Breneman D
J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
[TBL] [Abstract][Full Text] [Related]
30. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.
Koo JY; Fleischer AB; Abramovits W; Pariser DM; McCall CO; Horn TD; Gottlieb AB; Jaracz E; Rico MJ
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S195-205. PubMed ID: 16021175
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.
Reitamo S; Van Leent EJ; Ho V; Harper J; Ruzicka T; Kalimo K; Cambazard F; Rustin M; Taïeb A; Gratton D; Sauder D; Sharpe G; Smith C; Jünger M; de Prost Y;
J Allergy Clin Immunol; 2002 Mar; 109(3):539-46. PubMed ID: 11898004
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
33. Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis.
Wollenberg A; Sidhu MK; Odeyemi I; Dorsch B; Koehne-Volland R; Schaff M; Ehlken B; Berger K
Br J Dermatol; 2008 Dec; 159(6):1322-30. PubMed ID: 18782316
[TBL] [Abstract][Full Text] [Related]
34. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N
Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
[TBL] [Abstract][Full Text] [Related]
35. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.
Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus ointment (Protopic) for atopic dermatitis.
Pascual JC; Fleisher AB
Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
[TBL] [Abstract][Full Text] [Related]
37. Atopic dermatitis management with tacrolimus ointment (Protopic).
Kapp A; Allen BR; Reitamo S
J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
[TBL] [Abstract][Full Text] [Related]
38. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
Breneman D; Fleischer AB; Abramovits W; Zeichner J; Gold MH; Kirsner RS; Shull TF; Crowe AW; Jaracz E; Hanifin JM;
J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127
[TBL] [Abstract][Full Text] [Related]
39. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
Chapman MS; Schachner LA; Breneman D; Boguniewicz M; Gold MH; Shull T; Linowski GJ; Jaracz E;
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S177-85. PubMed ID: 16021173
[TBL] [Abstract][Full Text] [Related]
40. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
